Download App

Log in to access Online Inquiry
Company Overview More
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.
CEO: Chiminski, John R.
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > CTLT Catalent > Detailed Quotes

CTLT Catalent

100.040+2.220+2.27%
Trading Session 05/19 14:07 ET
High
101.570
Open
97.160
Turnover
45.63M
Low
97.160
Pre Close
97.820
Volume
456.41K
Market Cap
17.93B
P/E(TTM)
35.99
52wk High
142.640
Shares
179.21M
P/E(Static)
32.17
52wk Low
86.340
Float Cap
17.85B
Bid/Ask %
20.00%
Historical High
142.640
Shs Float
178.47M
Volume Ratio
0.65
Historical Low
18.920
Dividend TTM
--
Div Yield TTM
6600
P/B
3.87
Dividend LFY
--
Div Yield LFY
6597.36%
Turnover Ratio
0.26%
Amplitude
4.51%
Avg Price
99.981
Lot Size
1
Float Cap
17.85B
Bid/Ask %
20.00%
Historical High
142.640
Shs Float
178.47M
Volume Ratio
0.65
Historical Low
18.920
Dividend TTM
--
P/B
3.87
Dividend LFY
--
Turnover Ratio
0.26%
Amplitude
4.51%
Avg Price
99.981
Lot Size
1
Price Forecast

No Data

News

Comment